Improved fixation and cobalt-glucose oxidase-diaminobenzidine intensification for immunohistochemical demonstration of corticotropin- releasing factor in rat brainM Sakanaka, T Shibasaki and K Lederis
An optimal fixation method and intensification procedure may be required in brain immunohistochemistry to obtain intense and widespread staining for a specific antigen, in cases where ordinary fixation and conventional immunohistochemistry result in only partial demonstration of the antigen. In the present study of localization of corticotropin- releasing factor immunoreactivity (CRFI) in rat brain, the importance of such intensification is shown. We describe a fixation procedure in which perfusion of rat brain with Bouin's solution is followed by a PBS wash and a further perfusion with either Zamboni's fluid or 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4), for subsequent investigation of the detailed localization of CRFI in cerebral cortex and subcortical structures. The cobalt-glucose oxidase-diaminobenzidine (Co-GOD) intensification method has been modified to increase the sensitivity of immunostaining by reducing the concentration of glucose oxidase, which is added to the final incubation solution as a generator of hydrogen peroxide. The use of cobalt acetate instead of cobalt chloride appears to slightly suppress background staining in the Co-GOD method. Combination of the two modified procedures was applied to visualize intense and widespread CRFI in a variety of rat brain regions, including median eminence, cerebral cortex, and central amygdaloid nucleus.
Volume 35,
Issue 2,
pp. 207-212,
02/01/1987
|
|||||||||||||||||||||||||||||||||||||
![]() |
T.-C. Wen, J. Tanaka, H. Peng, J. Desaki, S. Matsuda, N. Maeda, H. Fujita, K. Sato, and M. Sakanaka Interleukin 3 Prevents Delayed Neuronal Death in the Hippocampal CA1 Field J. Exp. Med., August 17, 1998; 188(4): 635 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
E B Crenshaw, K Kalla, D M Simmons, L W Swanson, and M G Rosenfeld Cell-specific expression of the prolactin gene in transgenic mice is controlled by synergistic interactions between promoter and enhancer elements. Genes & Dev., July 1, 1989; 3(7): 959 - 972. [Abstract] [PDF] |
||||
| Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact |